Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

04/08/2023 06:00

Aug 4 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.75               27.69           104.00    
                 (-10.6 pct)         (+1.2 pct)       (+0.7 pct)  
  Operating          2.52                4.27             8.50    
                 (-41.0 pct)         (+34.0 pct)      (-0.1 pct)  
  Recurring          2.59                4.42             8.70    
                 (-41.3 pct)         (+31.2 pct)      (-4.2 pct)  
  Net                1.69                3.16             6.30    
                 (-46.5 pct)         (+18.9 pct)      (-5.3 pct)  
  EPS             46.24 yen           83.98 yen       172.68 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T